← All companies

CRBU

Caribou Biosciences, Inc.

CRBU Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$1.50

-0.01 -0.66%

Key statistics

from XBRL data in SEC filings

Market cap

$149M

Revenue (TTM)

$11.2M

Net income (TTM)

-$133M

EPS (TTM)

$-1.42

P/E ratio

—

Dividend yield

—

Free cash flow

-$112M

Cash

$12.1M

Total assets

$149M

Gross margin

—

52-week range

$1.38 – $3.54

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 18, 2026 8-K Regulation FD disclosure; Other events Jun 11, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Regulation FD disclosure; Other events Mar 31, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release) Mar 5, 2026 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Nov 3, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) Aug 12, 2025 8-K Other events Jun 23, 2025 8-K Shareholder vote results Jun 13, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Results of operations (earnings release); Exit or disposal costs; Other events Apr 24, 2025 10-K Fiscal year ended 2024-12-31 Mar 10, 2025 8-K Results of operations (earnings release) Mar 10, 2025 8-K Regulation FD disclosure Jan 13, 2025 8-K Director or officer change; Regulation FD disclosure Jan 2, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K/A Director or officer change Sep 27, 2024 8-K Director or officer change Sep 3, 2024 8-K Regulation FD disclosure; Other events Aug 12, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Results of operations (earnings release); Exit or disposal costs Jul 16, 2024 8-K Shareholder vote results Jun 14, 2024 8-K Regulation FD disclosure; Other events Jun 3, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K Regulation FD disclosure; Other events Apr 4, 2024 10-K Fiscal year ended 2023-12-31 Mar 11, 2024 8-K Results of operations (earnings release) Mar 11, 2024 8-K Regulation FD disclosure; Other events Jan 8, 2024 8-K Director or officer change Dec 22, 2023 8-K Director or officer change; Regulation FD disclosure; Other events Dec 12, 2023 10-Q/A Quarter ended 2023-06-30 Nov 17, 2023